Tronox Q2 2026 earnings: Revenue growth fails to prevent wider losses

Tronox (NYSE: TROX) reported Q2 2026 revenue of $868 million, up 19% from $731 million a year earlier, while its GAAP diluted loss per share widened to $1.07 from $0.53. Stronger TiO2 and zircon volumes lifted sales, but adjusted EBITDA fell 22% and its margin narrowed to 8.4%; free cash flow nevertheless turned positive at $60 million.

Core Earnings Data

Revenue growth was primarily volume-driven. TiO2 volumes rose 18% year over year, while zircon volumes increased 61%, more than offsetting weaker zircon pricing and mix.

Profitability moved in the opposite direction. Unfavorable currency movements, lower average pricing and mix, higher production costs, and increased freight and other costs reduced adjusted EBITDA, while a $103 million tax valuation allowance contributed to the wider GAAP net loss.

Dollar amounts are in millions except per-share data.

Business and Product Performance

TiO2 remained the largest source of revenue and benefited from the highest quarterly sales volume since Q2 2022. Its average price and mix were flat year over year but improved 5% sequentially as previously announced price increases took effect.

Zircon produced the fastest revenue growth, driven by constrained industry supply and sharply higher volumes. However, year-over-year pricing and mix fell 18%, limiting the earnings benefit from that volume growth.

Sequentially, TiO2 revenue rose 14% on 9% volume growth and a 5% improvement in pricing and mix. Zircon revenue increased 9%, with both volume and pricing contributing.

Profitability, Cash Flow, and Balance Sheet

Tronox generated $105 million of operating cash flow during Q2 and spent $45 million on capital expenditures, resulting in $60 million of free cash flow. Working-capital actions were an important contributor: management said total inventory declined by approximately $120 million from Q1 and reached its lowest value since June 2024.

Inventory stood at $1.458 billion on June 30, down from $1.652 billion at the end of 2025. The company nevertheless carried approximately $3.2 billion of total debt and $3.036 billion of net debt. Its trailing-12-month net leverage ratio increased to 11.4 times from 9.0 times at the end of 2025, while quarterly net interest expense rose to $56 million from $45 million.

Available liquidity totaled $527 million, consisting of $194 million in cash and $333 million available under revolving credit facilities. Tronox said its next significant debt maturity is in 2029.

Volume-Led Growth Did Not Translate Into Stronger Underlying Earnings

The central issue in Q2 was the divergence between sales and profitability. Higher TiO2 and zircon volumes drove the 19% revenue increase, but those gains did not offset weaker zircon pricing and mix, unfavorable foreign exchange movements, planned-outage costs, and higher freight and production expenses. As a result, adjusted EBITDA declined and its margin contracted by 430 basis points.

Conditions improved modestly from Q1: adjusted EBITDA rose 18% from $62 million, and the margin increased 20 basis points as TiO2 and zircon pricing each improved 5% sequentially. Meanwhile, the GAAP operating loss narrowed despite lower gross profit because restructuring and other charges fell to $4 million from $42 million. The net loss still widened, primarily reflecting the $103 million tax valuation allowance.

Guidance

Tronox expects Q3 adjusted EBITDA and margins to improve as pricing actions take effect and operating rates increase following the completion of extended outages. These benefits are expected to be partly offset by elevated input costs linked to volatility in the Middle East.

Management View

CEO John Romano said the cost-improvement program remains on track to deliver savings at the higher end of its $125 million to $175 million annual run-rate target by the end of 2026. Q2 costs included two planned outages, partly offset by the sale of lower-cost inventory.

Management is also restarting a furnace and advancing plans to resume production at the West Mine at Namakwa to support future product availability, including zircon inventory. Separately, Tronox expects the definitive feasibility study for its planned rare-earth cracking and leaching facility to conclude by Q3 2027, while prioritizing development options that limit incremental leverage.

Recent Insider Transactions

The supplied insider dataset reports 693,804 shares across 13 purchase transactions and 192,172 shares across six sales during the last six months, resulting in 501,632 net shares purchased. That represented 1.20% of total reported insider holdings of 40.79 million shares, although the transaction classifications include stock awards and should not automatically be treated as open-market purchases.

The 10 most recent entries consist of eight director stock awards and two executive sales. Individual share counts were not supplied for these records.

Risks Investors Need to Watch

• Margin recovery depends on price realization. Q3 guidance assumes higher TiO2 and zircon pricing, while elevated input costs could limit the resulting margin improvement.
• Volumes are expected to moderate. Seasonal TiO2 weakness and limited zircon inventory are expected to reduce Q3 volumes from Q2 levels.
• Leverage remains elevated. Net debt of $3.036 billion, an 11.4-times leverage ratio, and higher interest expense reduce financial flexibility despite adequate reported liquidity.
• Foreign exchange and product mix remain earnings headwinds. Both affected Q2 adjusted EBITDA, while zircon’s year-over-year price and mix decline offset part of its volume growth.
• Cash generation remains dependent on working-capital execution. Tronox expects relatively neutral Q3 free cash flow even while maintaining its full-year positive free-cash-flow outlook.

Summary

Tronox’s Q2 revenue growth was driven by substantially higher TiO2 and zircon volumes, but pricing, currency, and operating-cost pressures prevented that growth from reaching underlying earnings. Positive free cash flow and sequential pricing gains provided some support, while the $103 million tax valuation allowance widened the GAAP loss. The main issues to monitor are whether Q3 price increases and higher operating rates restore margins, whether full-year free cash flow remains positive, and how quickly the company can reduce its elevated leverage.